Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Faecalibacterium prausnitzii: Mechanistic Insights and Therapeutic Potential in Host-Microbe Crosstalk.

Created on 27 Oct 2026

Authors

Wenfei Qin, Guangqiang Wang, Yang Fu, Yue Zeng, Yongjun Xia, Yi Sheng, Lianzhong Ai

Published in

Probiotics and antimicrobial proteins. Oct 08, 2026. Epub Oct 08, 2026.

Abstract

Faecalibacterium prausnitzii (Fp), a potential candidate for a next-generation, is widely distributed in the feces and intestinal tract of mammals. Accumulating evidence indicates that Fp and its metabolites exert anti-inflammatory, immunomodulatory, and maintain intestinal barrier integrity. In this review, we summarize the biological characteristics of Fp and its nutritional cross feeding interactions with other microbial species. We further synthesize current evidence on the local roles of Fp in intestinal diseases and systemic effects on distant organs via the gut-organ axis. Furthermore, we outline the mechanisms by which its effector molecules, including butyrate, microbial anti-inflammatory molecule (MAM), and extracellular vesicles (EVs), contribute to disease amelioration. Finally, we discuss the current challenges and future perspectives for Fp. Collectively, as an important commensal bacterium in the gut, Fp provides a theoretical basis for the development of novel functional microorganisms with probiotic properties.

PMID:
42848175
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement